Healthcare & Life Sciences

Repron Therapeutics

series-c-plus

Stage

Investors

About

Developing therapeutics that silence transcription factors of oncogenes to treat cancer. Focused on creating novel drug candidates targeting transcriptional regulators implicated in oncogenesis.

Explore Repron Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.